Atai Life Sciences Statistics

Total Valuation

FRA:9VC has a market cap or net worth of EUR 894.36 million. The enterprise value is 822.64 million.

Market Cap	894.36M
Enterprise Value	822.64M

Important Dates

The last earnings date was Friday, August 15, 2025.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	214.34M
Shares Outstanding	n/a
Shares Change (YoY)	+7.97%
Shares Change (QoQ)	+11.51%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	116.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	454.89
PB Ratio	7.30
P/TBV Ratio	7.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.09
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.59

Financial Position

The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.08.

Current Ratio	4.02
Quick Ratio	3.81
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.15
Interest Coverage	-32.97

Financial Efficiency

Return on equity (ROE) is -76.50% and return on invested capital (ROIC) is -34.53%.

Return on Equity (ROE)	-76.50%
Return on Assets (ROA)	-29.51%
Return on Invested Capital (ROIC)	-34.53%
Return on Capital Employed (ROCE)	-58.41%
Revenue Per Employee	36,410
Profits Per Employee	-1.88M
Employee Count	54
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-99,626
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +239.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+239.71%
50-Day Moving Average	3.24
200-Day Moving Average	1.98
Relative Strength Index (RSI)	53.89
Average Volume (20 Days)	1,882

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.57

Income Statement

In the last 12 months, FRA:9VC had revenue of EUR 1.97 million and -101.67 million in losses. Loss per share was -0.59.

Revenue	1.97M
Gross Profit	1.97M
Operating Income	-81.40M
Pretax Income	-101.86M
Net Income	-101.67M
EBITDA	-80.76M
EBIT	-81.40M
Loss Per Share	-0.59

Full Income Statement

Balance Sheet

The company has 81.70 million in cash and 9.98 million in debt, giving a net cash position of 71.72 million.

Cash & Cash Equivalents	81.70M
Total Debt	9.98M
Net Cash	71.72M
Net Cash Per Share	n/a
Equity (Book Value)	122.55M
Book Value Per Share	0.58
Working Capital	65.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -64.35 million and capital expenditures -980,077, giving a free cash flow of -65.33 million.

Operating Cash Flow	-64.35M
Capital Expenditures	-980,077
Free Cash Flow	-65.33M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-4,140.32%
Pretax Margin	-5,181.03%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:9VC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.97%
Shareholder Yield	n/a
Earnings Yield	-11.37%
FCF Yield	-7.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:9VC has an Altman Z-Score of -3.06 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.06
Piotroski F-Score	3